Literature DB >> 33881586

[Therapeutic options in juvenile idiopathic arthritis : Surgical and conservative orthopedic rheumatological treatment].

J-P Haas1, M Arbogast2.   

Abstract

The treatment of juvenile idiopathic arthritis (JIA) has made substantial progress within the last 25 years. Modern medicinal treatment enables inflammatory activity of the disease to be controlled in most of the cases. Mutilating courses of disease, which were formerly the rule have now become the exception. Today remission of disease is the aim of pediatric rheumatological treatment. Apart from effective control of inflammation this includes complete restoration of functional abilities of affected joints and the surrounding structures also affected. To achieve this goal a holistic and foresighted view of each patient's course is required. Therefore, even in an apparently uncomplicated course of disease in some cases of JIA it is advisable to plan an early interdisciplinary consultation including the pediatric rheumatologist and the orthopedic surgeon, in order to discuss an early surgical intervention, which can then be carried out in a timely manner, if necessary. This article provides an overview of the orthopedic rheumatological indications and options.

Entities:  

Keywords:  Functional restoration; Inflammatory activity; Multidisciplinary treatment; Pediatric rheumatology; Remission

Year:  2021        PMID: 33881586     DOI: 10.1007/s00393-021-00996-3

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  41 in total

1.  [Physiotherapy for juvenile idiopathic arthritis].

Authors:  M Spamer; M Georgi; R Häfner; H Händel; M König; J-P Haas
Journal:  Z Rheumatol       Date:  2012-07       Impact factor: 1.372

2.  Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997.

Authors:  R E Petty; T R Southwood; J Baum; E Bhettay; D N Glass; P Manners; J Maldonado-Cocco; M Suarez-Almazor; J Orozco-Alcala; A M Prieur
Journal:  J Rheumatol       Date:  1998-10       Impact factor: 4.666

3.  Efficacy of a land-based home exercise programme for patients with juvenile idiopathic arthritis: a randomized, controlled, single-blind study.

Authors:  Ela Tarakci; Ipek Yeldan; S Nilay Baydogan; Seref Olgar; Ozgur Kasapcopur
Journal:  J Rehabil Med       Date:  2012-11       Impact factor: 2.912

4.  Evidence and consensus based GKJR guidelines for the treatment of juvenile idiopathic arthritis.

Authors:  Gregor Dueckers; Nihal Guellac; Martin Arbogast; Guenther Dannecker; Ivan Foeldvari; Michael Frosch; Gerd Ganser; Arnd Heiligenhaus; Gerd Horneff; Arnold Illhardt; Ina Kopp; Ruediger Krauspe; Barbara Markus; Hartmut Michels; Matthias Schneider; Wolfram Singendonk; Helmut Sitter; Marianne Spamer; Norbert Wagner; Tim Niehues
Journal:  Clin Immunol       Date:  2011-10-26       Impact factor: 3.969

5.  Evaluation of the ILAR criteria for juvenile idiopathic arthritis.

Authors:  M Krumrey-Langkammerer; R Häfner
Journal:  J Rheumatol       Date:  2001-11       Impact factor: 4.666

6.  Effects of juvenile idiopathic arthritis on kinematics and kinetics of the lower extremities call for consequences in physical activities recommendations.

Authors:  M Hartmann; F Kreuzpointner; R Haefner; H Michels; A Schwirtz; J P Haas
Journal:  Int J Pediatr       Date:  2010-09-02

Review 7.  Exercise therapy in juvenile idiopathic arthritis: a Cochrane Review.

Authors:  T Takken; M Van Brussel; R H H Engelbert; J Van Der Net; W Kuis; P J M Helders
Journal:  Eur J Phys Rehabil Med       Date:  2008-09       Impact factor: 2.874

8.  Rheumatoid arthritis is the major risk factor for septic arthritis in rheumatological settings.

Authors:  M Favero; F Schiavon; L Riato; V Carraro; L Punzi
Journal:  Autoimmun Rev       Date:  2008-08-13       Impact factor: 9.754

9.  Methotrexate therapy in juvenile rheumatoid arthritis: a retrospective study.

Authors:  H Truckenbrodt; R Häfner
Journal:  Arthritis Rheum       Date:  1986-06

10.  The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception cohort.

Authors:  Claudia Sengler; Jens Klotsche; Martina Niewerth; Ina Liedmann; Dirk Föll; Arnd Heiligenhaus; Gerd Ganser; Gerd Horneff; Johannes-Peter Haas; Kirsten Minden
Journal:  RMD Open       Date:  2015-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.